Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Layilin is a C-type lectin receptor.1 It is composed of an extracellular region that contains the C-type lectin homology domain, a transmembrane domain, and a cytoplasmic domain. Layilin is ubiquitously expressed and localizes to the cell surface, but has also been found in mitochondria.1,2 It is involved in cell migration, the epithelial-to-mesenchymal transition (EMT), and antitumor immunity and binds to the extracellular matrix proteins hyaluronan and glycosylated collagen, as well as the cytoskeleton-membrane linker proteins talin, merlin, and radixin.1,3,4,5 The layilin isoform 2 extracellular domain binds to melanoma cells in a calcium-dependent manner.5 Knockout of LAYN prevents the accumulation of lymph node-derived CD8+ tumor-infiltrating lymphocytes (TILs) in a competitive adoptive transfer murine colon adenocarcinoma model.6 Layilin protein levels are increased in CD8+ TILs that highly express programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte protein 4 (CTLA-4) isolated from patients with metastatic melanoma. Cayman’s Layilin Isoform 2 Extracellular Domain (human, recombinant) protein consists of 437 amino acids, has a calculated molecular weight of 49.5 kDa, and a predicted N-terminus of Ala22 after signal peptide cleavage. By SDS-PAGE, under reducing conditions, the apparent molecular mass of the protein is 60-65 kDa due to glycosylation.
WARNING This product is not for human or veterinary use.
1. Layilin, a novel talin-
2. Layilin promotes mitochondrial fission by cyclin-
3. Roles of layilin in TNF-
4. Hyaluronan receptors as mediators and modulators of the tumor microenvironment. Adv. Healthc. Mater. e2202118 (2022).
5. Identifying and antagonizing the interactions between layilin and glycosylated collagens. Cell Chem. Biol. 29(4), 597-604 (2022).
6. Layilin augments integrin activation to promote antitumor immunity. J. Exp. Med. 217(9), e20192080 (2020).